ArticleDigestive diseases and sciences2026
Trends in Incidence and Prevalence of Acute Pancreatitis in the United States: A Population-Based Analysis from 1995 to 2024.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNationwide trends in the incidence and prevalence of acute pancreatitis (AP), a leading cause of gastrointestinal hospitalization in the United States (US), remain insufficiently characterized. This study aims to describe the temporal trends in the incidence and prevalence of AP, as well as by etiology, in the US from 1995 to 2024.
methodsAdults with AP were identified using TriNetX, a database encompassing over 120 million US individuals, between 1995 and 2024, using ICD-9 and ICD-10-CM codes. Etiologies were identified using ICD-10-CM codes from 2016. Annual age-standardized incidence rates (ASIR) and prevalence rates (ASPR) per 100,000 persons standardized to the 2000 US census population were calculated. Joinpoint regression identified temporal changes in ASIRs and ASPRs, reporting annual percentage changes (APCs) and average APCs (AAPCs), along with 95% confidence intervals (95%CIs). Interrupted time-series analysis assessed the impact of key events on AP trends.
resultsBetween 1995 and 2024, 558,264 AP cases were identified. ASIR increased from 23.05 per 100,000 in 1999 to 116.69 per 100,000 in 2024 (AAPC 4.81%; 95%CI, 3.95-5.69; p < 0.001), while ASPR rose from 68.52 per 100,000 in 1995 to 615.72 per 100,000 in 2024 (AAPC 6.66%; 95%CI, 6.23-7.08; p < 0.001). Rates were consistently higher in males, although AAPCs were similar across sexes. Incidence of alcohol-induced AP increased significantly since 2016, particularly among females, while drug-induced, gallstone, and idiopathic etiologies remained stable.
conclusionsThe incidence and prevalence of AP in the US rose substantially over three decades. Alcohol-induced AP is the only etiology with a significant increase in incidence regardless of sex.
Indexed as
Identifiers
42201495What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.